These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 540344)

  • 1. Effect of lipid solubility and dose on the elimination of barbiturates in rabbits.
    Kaneniwa N; Hiura M; Nakagawa S
    Chem Pharm Bull (Tokyo); 1979 Jul; 27(7):1501-9. PubMed ID: 540344
    [No Abstract]   [Full Text] [Related]  

  • 2. K5 values of some homologous series of barbiturates and the relationship with the lipophilicity and metabolic clearance.
    Yih TD; van Rossum JM
    Biochem Pharmacol; 1977 Nov; 26(22):2117-20. PubMed ID: 588293
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotransformation of thiopental and other thiobarbiturates.
    Dundee JW
    Int Anesthesiol Clin; 1974; 12(2):121-33. PubMed ID: 4846712
    [No Abstract]   [Full Text] [Related]  

  • 4. Binding of barbiturates to hepatic microsomes of the rat.
    Sitar DS; Mannering GJ
    Biochem Pharmacol; 1977 May; 26(10):988-91. PubMed ID: 861047
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethanol as a selective inhibitor of microsomal barbiturate hydroxylation in vitro and in vivo.
    Schüppel RV; Kuthe C
    Adv Exp Med Biol; 1980; 132():363-72. PubMed ID: 7424717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsomal epoxidation of cis-stilbene: decrease in epoxidase activity related to lipid peroxidation.
    Watabe T; Akamatsu K
    Biochem Pharmacol; 1974 Mar; 23(6):1079-85. PubMed ID: 4151051
    [No Abstract]   [Full Text] [Related]  

  • 7. A study of the interaction of a series of substituted barbituric acids with the hepatic microsomal monooxygenase.
    Jansson I; Orrenius S; Ernster L; Schenkman JB
    Arch Biochem Biophys; 1972 Aug; 151(2):391-400. PubMed ID: 4402992
    [No Abstract]   [Full Text] [Related]  

  • 8. ON THE RELATIONSHIP BETWEEN LIPID SOLUBILITY AND MICROSOMAL METABOLISM OF DRUGS.
    MAZEL P; HENDERSON JF
    Biochem Pharmacol; 1965 Jan; 14():92-4. PubMed ID: 14286109
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of microsomal drug metabolism by 2-((2-(4-pyridyl)-methyl)-thio)-benzimidazole (H-718).
    Varga F; Fischer E; Szily T
    Acta Physiol Acad Sci Hung; 1973; 44(3-4):227-34. PubMed ID: 4807135
    [No Abstract]   [Full Text] [Related]  

  • 10. Stereospecificity of anesthetic activity, distribution, inactivation and protein binding of the optical antipodes of two N-methylated barbiturates.
    Büch H; Knabe J; Buzello W; Rummel W
    J Pharmacol Exp Ther; 1970 Dec; 175(3):709-16. PubMed ID: 5496138
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of some barbiturate derivatives to epoxides in rat liver microsomes.
    Pachecka J; Słojkowska Z; Opioła E
    Acta Pol Pharm; 1979; 36(5):613-7. PubMed ID: 44961
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of some homologous series of barbiturates in the intact rat and in the isolated perfused rat liver.
    Yih TD; van Rossum JM
    J Pharmacol Exp Ther; 1977 Oct; 203(1):184-92. PubMed ID: 909052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of hepatic drug-metabolizing enzymes by thiophosphate insecticides and its drug toxicological implications.
    Uchiyama M; Yoshida T; Homma K; Hongo T
    Biochem Pharmacol; 1975 Jun; 24(11-12):1221-5. PubMed ID: 1137607
    [No Abstract]   [Full Text] [Related]  

  • 14. Metabolism of 1,3-dicyclohexyl-5,5-diallylbarbituric acid in rabbits.
    Chyczewski T
    Pol J Pharmacol Pharm; 1973; 25(4):379-84. PubMed ID: 4774246
    [No Abstract]   [Full Text] [Related]  

  • 15. Biotransformation of N-methylcyclobarbital in vivo in rabbit and rat.
    Miyano K; Shimodouzono Y; Toki S
    Xenobiotica; 1985 May; 15(5):381-9. PubMed ID: 2863899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. THE DEMETHYLATION IN VITRO OF N-METHYL BARBITURATES AND RELATED COMPOUNDS BY MAMMALIAN LIVER MICROSOMES.
    MCMAHON RE
    Biochem Pharmacol; 1963 Oct; 12():1225-8. PubMed ID: 14074123
    [No Abstract]   [Full Text] [Related]  

  • 17. Butobarbitone metabolism in man: identification of 3'-ketobutobarbitone.
    Grove J; Toseland PA; Draffan GH; Clare RA; Williams FM
    J Pharm Pharmacol; 1974 Mar; 26(3):175-8. PubMed ID: 4151075
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of some possible mechanisms by which glucose inhibits drug metabolism in vivo and in vitro.
    Peters MA; Strother A
    J Pharmacol Exp Ther; 1972 Jan; 180(1):151-7. PubMed ID: 4400875
    [No Abstract]   [Full Text] [Related]  

  • 19. The metabolism of 1-n-butyl-5,5-diethylbarbituric acid (N-n-butyl barbital) in the rat. II. Distribution of the drug and its metabolites in various tissues in vivo and in the isolated perfused liver system.
    Vore M; Bush MT
    J Pharmacol Exp Ther; 1980 Jan; 212(1):103-8. PubMed ID: 7351617
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of fasting on the elimination of barbital and phenobarbital in rabbits.
    Kaneniwa N; Hiura M; Funaki T
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2157-62. PubMed ID: 519811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.